Navigation Links
MBS Value Partners Hires Two New Senior Staff Members
Date:2/8/2010

NEW YORK, Feb. 8 /PRNewswire/ -- MBS Value Partners, a strategic communications firm specializing in investor relations and corporate communications for domestic and international clients, announced today that Lisa Lettieri and Matthew Haines have joined as Managing Directors.

“Lisa and Matt bring outstanding senior-level advisory and corporate experience that will serve our clients well,” said Lynn Morgen, co-founder of MBS. “Lisa’s and Matt’s significant experience in clean technology and health care / biotechnology, respectively, complement our existing expertise in technology, business/industrial services, media and consumer businesses, and will enable us to further leverage our knowledge base, network of financial community relationships and crisis expertise for the benefit of our clients."

Lisa Lettieri brings more than a dozen years of integrated corporate communications and strategic planning experience to MBS. Most recently she headed Investor Relations and Corporate Communications for FuelCell Energy, a Nasdaq-listed manufacturer of high-efficiency ultra-clean power plants headquartered in Danbury, Connecticut. Prior to that she was Vice President of Investor Relations at Champion Enterprises, Inc., a factory homebuilder and was previously Director of Corporate Communications with responsibility for investor relations at Scientific Games Corporation. Lisa was an institutional investment professional for 15 years prior to becoming a corporate communications specialist. She holds a BS in Marketing from Manhattan College and an MBA in Finance from Fordham University in New York.

Matt Haines brings more than 20 years of investor relations, media relations, and corporate communications experience in health care and biotechnology. Prior to joining MBS, Matt served as Senior Director of Investor Relations and Corporate Communications at MDRNA, Inc., a biotechnology company developing RNAi therapeutics and delivery systems. Earlier, Matt served as Senior Director of Investor Relations and Corporate Communications at Nastech Pharmaceutical Company Inc. and as Director of Corporate Communications at OSI Pharmaceuticals, Inc. Matt's career includes almost 10 years of health care agency experience in increasingly responsible positions. Matt holds a BA in Political Science from New York University and an MBA in Marketing from NYU's Stern School of Business.

ABOUT MBS VALUE PARTNERS

MBS Value Partners, headquartered in New York City, is a strategic communications firm that provides senior level advisory work and customized investor relations, financial media and corporate communications programs for a growing roster of domestic and international clients. For additional information, please visit www.mbsvalue.com.

SOURCE MBS Value Partners

RELATED LINKS
http://www.mbsvalue.com

'/>"/>

SOURCE MBS Value Partners
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
2. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
3. Industry Executives Finding Value in Shift of Scientific Publications
4. Top Health Care Economists and Physician-Innovators Discuss Value of Medical Technology at AdvaMed 2007 Conference
5. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
6. ValueRich Report on AMDL/China Available on Web Site
7. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
8. AMDL Expands Drug Distribution in China With Additional Agreement, Valued at $2.3 Million Annually
9. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
10. Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
11. Industry Executives Finding Value in Shift of Scientific Publications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... today announces publication of a United States multicenter, prospective clinical study that ... disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial and ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology:
(Date:6/14/2017)...  IBM (NYSE: IBM ) is introducing several innovative ... to developing collaboration between startups and global businesses, taking place ... the event, nine startups will showcase the solutions they have ... France is one ... a 30 percent increase in the number of startups created ...
(Date:4/24/2017)... April 24, 2017 Janice Kephart ... with  Identity Strategy Partners, LLP (IdSP) , today ... without President Trump,s March 6, 2017 Executive ... , refugee vetting can be instilled with greater confidence, ... now, all refugee applications are suspended by until ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):